161 related articles for article (PubMed ID: 33588739)
21. Clinical pharmacokinetics of tacrolimus in rescue therapy after renal transplantation.
Budde K; Fritsche L; Mai I; Bauer S; Smettan S; Waiser J; Hofmann T; Hauser I; Reinke P; Neumayer HH
Int J Clin Pharmacol Ther; 1996 Nov; 34(11):493-7. PubMed ID: 8937932
[TBL] [Abstract][Full Text] [Related]
22. De novo use of a generic formulation of tacrolimus versus reference tacrolimus in kidney transplantation: evaluation of the clinical results, histology in protocol biopsies, and immunological monitoring.
Melilli E; Crespo E; Sandoval D; Manonelles A; Sala N; Mast R; Padulles A; Grinyo JM; Bestard O; Cruzado JM
Transpl Int; 2015 Nov; 28(11):1283-90. PubMed ID: 26088437
[TBL] [Abstract][Full Text] [Related]
23. A UK analysis of the cost of switching renal transplant patients from an immediate-release to a prolonged-release formulation of tacrolimus based on differences in trough concentration variability.
Muduma G; Odeyemi I; Pollock RF
J Med Econ; 2014 Jul; 17(7):520-6. PubMed ID: 24754700
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the long-term efficacy and safety of generic tacrolimus, Tacrobell, with Prograf in liver transplant recipients.
Choi HJ; Kim DG; Kwak BJ; Han JH; Hong TH; You YK
Drug Des Devel Ther; 2018; 12():295-301. PubMed ID: 29483770
[TBL] [Abstract][Full Text] [Related]
25. New formulations of tacrolimus and prevention of acute and chronic rejections in adult kidney-transplant recipients.
Jouve T; Rostaing L; Malvezzi P
Expert Opin Drug Saf; 2017 Jul; 16(7):845-855. PubMed ID: 28494654
[TBL] [Abstract][Full Text] [Related]
26. Conversion of stable kidney transplant recipients from a twice daily Prograf-based regimen to a once daily modified release tacrolimus-based regimen.
Alloway R; Steinberg S; Khalil K; Gourishankar S; Miller J; Norman D; Hariharan S; Pirsch J; Matas A; Zaltzman J; Wisemandle K; Fitzsimmons W; First MR
Transplant Proc; 2005 Mar; 37(2):867-70. PubMed ID: 15848559
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic Study of Conversion Between 2 Formulations of Once-daily Extended-release Tacrolimus in Stable Lung Transplant Patients.
Sintes H; Sáez-Giménez B; Berastegui C; López-Meseguer M; Monforte V; Bravo C; Vima J; Gómez-Ollés S; Roman A
Transplantation; 2018 Oct; 102(10):e439-e446. PubMed ID: 29965950
[TBL] [Abstract][Full Text] [Related]
28. Clinically Significant Drug Interaction Between Clotrimazole and Tacrolimus in Pancreas Transplant Recipients and Associated Risk of Allograft Rejection.
Viesselmann CW; Descourouez JL; Jorgenson MR; Radke NA; Odorico JS
Pharmacotherapy; 2016 Mar; 36(3):335-41. PubMed ID: 26877191
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and Safety Evaluation After Conversion From Twice-Daily to Once-Daily Tacrolimus in Stable Liver Transplant Recipients: A Phase 4, Open-Label, Single-Center Study.
Kang WH; Song GW; Moon DB; Hwang S; Kim KH; Jung DH; Park GC; Yoon YI; Cho HD; Kim M; Kim SH; Na BG; Kim SM; Yang G; Lee SG
Transplant Proc; 2021 Dec; 53(10):3000-3006. PubMed ID: 34776265
[TBL] [Abstract][Full Text] [Related]
30. Conversion of twice-daily to once-daily tacrolimus is safe in stable adult living donor liver transplant recipients.
Kim SH; Lee SD; Kim YK; Park SJ
Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):374-9. PubMed ID: 26256081
[TBL] [Abstract][Full Text] [Related]
31. Clinical outcomes associated with conversion from brand-name to generic tacrolimus in hospitalized kidney transplant recipients.
Heavner MS; Tichy EM; Yazdi M; Formica RN; Kulkarni S; Emre S
Am J Health Syst Pharm; 2013 Sep; 70(17):1507-12. PubMed ID: 23943182
[TBL] [Abstract][Full Text] [Related]
32. Conversion to prolonged release tacrolimus formulation in stable kidney transplant recipients.
Wu SW; Tsai HC; Tsai PY; Hung TW; Chang HR; Lian JD
Swiss Med Wkly; 2013; 143():w13850. PubMed ID: 23986367
[TBL] [Abstract][Full Text] [Related]
33. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
34. Tacrolimus trough levels higher than 6 ng/mL might not be required after a year in stable kidney transplant recipients.
Jung HY; Seo MY; Jeon Y; Huh KH; Park JB; Jung CW; Lee S; Han SY; Ro H; Yang J; Ahn C; Choi JY; Cho JH; Park SH; Kim YL; Kim CD
PLoS One; 2020; 15(7):e0235418. PubMed ID: 32614859
[TBL] [Abstract][Full Text] [Related]
35. Trough level from twice daily to once daily tacrolimus in early conversion kidney transplant recipients: a prospective study.
Sukkha S; Chindavijak B; Montakantikul P; Ingsathit A; Nosoongnoen W; Sumethkul V
Int J Clin Pharm; 2017 Dec; 39(6):1298-1303. PubMed ID: 29101615
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic monitoring of pediatric transplant patients with conversion to generic tacrolimus.
Riva N; Cáceres Guido P; Licciardone N; Imventarza O; Monteverde M; Staciuk R; Charroqui A; Schaiquevich P
Farm Hosp; 2017 Mar; 41(2):150-168. PubMed ID: 28236795
[TBL] [Abstract][Full Text] [Related]
37. Use of generic tacrolimus in elderly renal transplant recipients: precaution is needed.
Robertsen I; Åsberg A; Ingerø AO; Vethe NT; Bremer S; Bergan S; Midtvedt K
Transplantation; 2015 Mar; 99(3):528-32. PubMed ID: 25148382
[TBL] [Abstract][Full Text] [Related]
38. Identifying the association between tacrolimus exposure and toxicity in heart and lung transplant recipients: A systematic review.
Braithwaite HE; Darley DR; Brett J; Day RO; Carland JE
Transplant Rev (Orlando); 2021 Apr; 35(2):100610. PubMed ID: 33756310
[TBL] [Abstract][Full Text] [Related]
39. Conversion from twice-daily to once-daily extended-release tacrolimus in renal transplant recipients: 2-year results and review of the literature.
Tran D; Vallée M; Collette S; Senécal L; Lafrance JP; Dandavino R; Boucher A
Exp Clin Transplant; 2014 Aug; 12(4):323-7. PubMed ID: 24844288
[TBL] [Abstract][Full Text] [Related]
40. Changes in the commercial brand of tacrolimus lead to subtherapeutic trough levels and acute rejection in renal transplant recipients.
Arreola-Guerra JM; Alberú J; Chew-Wong A; Macias DM; Hernández-Rosales J; Zuñiga-Macías L; Delgadillo-Castañeda R; Ricalde-Ríos G; Haro-Alcalde F; Villafán-Bernal JR; Ramos-Medellín CL; Reyes-Acevedo R
Clin Transplant; 2019 Dec; 33(12):e13749. PubMed ID: 31691354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
